Please enable JavaScript to continue using this application.

Compare $ARTV vs $BNTC | Chartloom

Compare

$ARTV vs $BNTC

Artiva Biotherapeutics Inc · Benitec Biopharma Inc

ARTV

Artiva Biotherapeutics Inc

BNTC

Benitec Biopharma Inc

Compare $ARTV vs $BNTC

Comparing Artiva Biotherapeutics Inc and Benitec Biopharma Inc

ARTVArtiva Biotherapeutics Inc

BNTCBenitec Biopharma Inc

ARTVArtiva Biotherapeutics Inc

Market cap

$337M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

64.1%

52W performance

131.3%

FCF yield

-22.8%

BNTCBenitec Biopharma Inc

Market cap

$305M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-29.5%

52W performance

-37.1%

FCF yield

-5.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ARTV

BNTC

Detailed metrics comparison

ARTV

Artiva Biotherapeutics Inc

BNTC

Benitec Biopharma Inc

Market Cap

ARTV$337M

BNTC$305M

Enterprise Value

ARTV$36M

BNTC$125M

Price

ARTV$6.94

BNTC$8.87

P/E Ratio

ARTVN/A

BNTCN/A

P/S Ratio

ARTV0.00x

BNTC4,474.96x

EV/Sales

ARTV0.00x

BNTC1,903.93x

EV/EBITDA

ARTV0.00x

BNTC0.00x

P/B Ratio

ARTV0.96x

BNTC1.77x

P/FCF Ratio

ARTVN/A

BNTCN/A

EV/FCF

ARTV-0.46x

BNTC-7.50x

PEG Ratio

ARTVN/A

BNTCN/A

Forward P/E (NTM)

ARTVN/A

BNTCN/A

Forward P/S (NTM)

ARTVN/A

BNTCN/A

Revenue (TTM)

ARTV$0

BNTC$0

Revenue Growth (YoY)

ARTVN/A

BNTCN/A

Forward Rev Growth

ARTV404.4%

BNTC13.8%

Gross Margin (TTM)

ARTV0.0%

BNTC100.0%

Operating Margin (TTM)

ARTV0.0%

BNTC0.0%

EBITDA Margin (TTM)

ARTV0.0%

BNTC0.0%

Net Margin (TTM)

ARTV0.0%

BNTC0.0%

FCF Margin (TTM)

ARTVN/A

BNTCN/A

Net Income (TTM)

ARTV$-42M

BNTC$-33M

FCF (TTM)

ARTV$-77M

BNTC$-17M

EPS (TTM)

ARTV$0.00

BNTC$0.00

ROE (TTM)

ARTV-6022.0%

BNTC-3482.0%

ROA (TTM)

ARTV-5238.0%

BNTC-3411.0%

ROIC (TTM)

ARTV-6019.0%

BNTC-3482.0%

Cash

ARTV$301M

BNTC$180M

Debt

ARTV$0

BNTC$0

Net Cash/Debt

ARTV$301M

BNTC$180M

Current Ratio (TTM)

ARTV24.16x

BNTC34.00x

Quick Ratio (TTM)

ARTV23.97x

BNTC33.70x

Debt/Equity (TTM)

ARTV0.00x

BNTC0.00x

Debt/Assets (TTM)

ARTV0.0%

BNTC0.0%

Interest Coverage (TTM)

ARTVN/A

BNTCN/A

Net Debt/EBITDA (TTM)

ARTV0.00x

BNTC0.00x

Beta

ARTV5.80

BNTC0.23

52W Performance

ARTV131.3%

BNTC-37.1%

YTD Performance

ARTV64.1%

BNTC-29.5%

% from 52W High

ARTV-52.2%

BNTC-47.1%

% from 52W Low

ARTV156.1%

BNTC4.1%

Asset Turnover (TTM)

ARTV0.00x

BNTC0.01x

FCF Yield (TTM)

ARTV-22.8%

BNTC-5.5%

Earnings Yield (TTM)

ARTV-12.5%

BNTC-10.7%

Dividend Yield (TTM)

ARTVN/A

BNTCN/A

Rule of 40

ARTV0.0

BNTC0.0

EV/GP/RG

ARTVN/A

BNTCN/A

Ticker research

View ARTV research View BNTC research

Metric	ARTV Artiva Biotherapeutics Inc	BNTC Benitec Biopharma Inc
Market & Valuation
Market Cap	$337M	$305M
Enterprise Value	$36M	$125M
Price	$6.94	$8.87
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	4,474.96x
EV/Sales	0.00x	1,903.93x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.96x	1.77x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.46x	-7.50x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	404.4%	13.8%
Profitability
Gross Margin (TTM)	0.0%	100.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-42M	$-33M
FCF (TTM)	$-77M	$-17M
EPS (TTM)	$0.00	$0.00
ROE (TTM)	-6022.0%	-3482.0%
ROA (TTM)	-5238.0%	-3411.0%
ROIC (TTM)	-6019.0%	-3482.0%
Financial Health
Cash	$301M	$180M
Debt	$0	$0
Net Cash/Debt	$301M	$180M
Current Ratio (TTM)	24.16x	34.00x
Quick Ratio (TTM)	23.97x	33.70x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	5.80	0.23
52W Performance	131.3%	-37.1%
YTD Performance	64.1%	-29.5%
% from 52W High	-52.2%	-47.1%
% from 52W Low	156.1%	4.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-22.8%	-5.5%
Earnings Yield (TTM)	-12.5%	-10.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ARTV research	View BNTC research

Valuation

P/S Ratio

ARTV

0.00x

BNTC

4,474.96x

EV/FCF

BNTC

-7.50x

ARTV

-0.46x

Growth & revenue

Forward Revenue Growth

ARTV

404.4%

BNTC

13.8%

Profitability & performance

Gross Margin

BNTC

100.0%

ARTV

0.0%

ROE

BNTC

-3482.0%

ARTV

-6022.0%

FCF Yield %

BNTC

-5.5%

ARTV

-22.8%

52-Week Performance

ARTV

131.3%

BNTC

-37.1%

Detailed metrics comparison

ARTV

Artiva Biotherapeutics Inc

BNTC

Benitec Biopharma Inc

Market Cap

ARTV$337M

BNTC$305M

Enterprise Value

ARTV$36M

BNTC$125M

Price

ARTV$6.94

BNTC$8.87

P/E Ratio

ARTVN/A

BNTCN/A

P/S Ratio

ARTV0.00x

BNTC4,474.96x

EV/Sales

ARTV0.00x

BNTC1,903.93x

EV/EBITDA

ARTV0.00x

BNTC0.00x

P/B Ratio

ARTV0.96x

BNTC1.77x

P/FCF Ratio

ARTVN/A

BNTCN/A

EV/FCF

ARTV-0.46x

BNTC-7.50x

PEG Ratio

ARTVN/A

BNTCN/A

Forward P/E (NTM)

ARTVN/A

BNTCN/A

Forward P/S (NTM)

ARTVN/A

BNTCN/A

Revenue (TTM)

ARTV$0

BNTC$0

Revenue Growth (YoY)

ARTVN/A

BNTCN/A

Forward Rev Growth

ARTV404.4%

BNTC13.8%

Gross Margin (TTM)

ARTV0.0%

BNTC100.0%

Operating Margin (TTM)

ARTV0.0%

BNTC0.0%

EBITDA Margin (TTM)

ARTV0.0%

BNTC0.0%

Net Margin (TTM)

ARTV0.0%

BNTC0.0%

FCF Margin (TTM)

ARTVN/A

BNTCN/A

Net Income (TTM)

ARTV$-42M

BNTC$-33M

FCF (TTM)

ARTV$-77M

BNTC$-17M

EPS (TTM)

ARTV$0.00

BNTC$0.00

ROE (TTM)

ARTV-6022.0%

BNTC-3482.0%

ROA (TTM)

ARTV-5238.0%

BNTC-3411.0%

ROIC (TTM)

ARTV-6019.0%

BNTC-3482.0%

Cash

ARTV$301M

BNTC$180M

Debt

ARTV$0

BNTC$0

Net Cash/Debt

ARTV$301M

BNTC$180M

Current Ratio (TTM)

ARTV24.16x

BNTC34.00x

Quick Ratio (TTM)

ARTV23.97x

BNTC33.70x

Debt/Equity (TTM)

ARTV0.00x

BNTC0.00x

Debt/Assets (TTM)

ARTV0.0%

BNTC0.0%

Interest Coverage (TTM)

ARTVN/A

BNTCN/A

Net Debt/EBITDA (TTM)

ARTV0.00x

BNTC0.00x

Beta

ARTV5.80

BNTC0.23

52W Performance

ARTV131.3%

BNTC-37.1%

YTD Performance

ARTV64.1%

BNTC-29.5%

% from 52W High

ARTV-52.2%

BNTC-47.1%

% from 52W Low

ARTV156.1%

BNTC4.1%

Asset Turnover (TTM)

ARTV0.00x

BNTC0.01x

FCF Yield (TTM)

ARTV-22.8%

BNTC-5.5%

Earnings Yield (TTM)

ARTV-12.5%

BNTC-10.7%

Dividend Yield (TTM)

ARTVN/A

BNTCN/A

Rule of 40

ARTV0.0

BNTC0.0

EV/GP/RG

ARTVN/A

BNTCN/A

Ticker research

View ARTV research View BNTC research

Metric	ARTV Artiva Biotherapeutics Inc	BNTC Benitec Biopharma Inc
Market & Valuation
Market Cap	$337M	$305M
Enterprise Value	$36M	$125M
Price	$6.94	$8.87
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	4,474.96x
EV/Sales	0.00x	1,903.93x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.96x	1.77x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.46x	-7.50x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	404.4%	13.8%
Profitability
Gross Margin (TTM)	0.0%	100.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-42M	$-33M
FCF (TTM)	$-77M	$-17M
EPS (TTM)	$0.00	$0.00
ROE (TTM)	-6022.0%	-3482.0%
ROA (TTM)	-5238.0%	-3411.0%
ROIC (TTM)	-6019.0%	-3482.0%
Financial Health
Cash	$301M	$180M
Debt	$0	$0
Net Cash/Debt	$301M	$180M
Current Ratio (TTM)	24.16x	34.00x
Quick Ratio (TTM)	23.97x	33.70x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	5.80	0.23
52W Performance	131.3%	-37.1%
YTD Performance	64.1%	-29.5%
% from 52W High	-52.2%	-47.1%
% from 52W Low	156.1%	4.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-22.8%	-5.5%
Earnings Yield (TTM)	-12.5%	-10.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ARTV research	View BNTC research